Radiation therapy in the hypofractionation mode on the Halcyon elite linear accelerator: the first experience of St. Petersburg city clinical oncology dispensary
Open Access
- 17 October 2024
- journal article
- Published by Association of Oncologist Real Clinical Practice OncoPractitioner in Clinical Case in Oncology
- Vol. 2 (2) , 23-28
Abstract
Stereotactic radiation therapy in the hypofractionation mode is a method in which high doses of ionizing radiation (more than 3 Gy per fraction) are delivered in a small number of fractions (from 2 to 5). Treatment and the process of preparation for it are carried out using special fixing devices, dosimetric planning techniques of high conformity, with control of the treatment position using x-ray imaging. which makes it possible to ensure the required irradiation accuracy. The advantages are a shorter course of treatment compared to standard fractionation, a high biologically effective dose, a reduced effect of tumor repopulation, greater efficiency under hypoxic conditions, and satisfactory results when irradiating radioresistant tumors. The article presents clinical cases of the use of hypofractionation modes on the Halcyon elite linear accelerator.Keywords
This publication has 9 references indexed in Scilit:
- Hypofractionated Radiotherapy in Localized, Low–Intermediate-Risk Prostate Cancer: Current and Future ProspectivesMedicina, 2023
- Head and neck cancer: hypofractionated adjuvant radiation therapyDiagnostic radiology and radiotherapy, 2023
- Advances in radiotherapy in bone metastases in the context of new target therapies and ablative alternatives: A critical reviewRadiotherapy and Oncology, 2021
- Radiation therapy for oligometastatic cancerMalignant tumours, 2021
- Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO surveyRadiotherapy and Oncology, 2021
- Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trialThe Lancet, 2019
- Hypofractionated radiotherapy for glioblastoma: changing the radiation treatment paradigmBurdenko's Journal of Neurosurgery, 2017
- Survey of Current Practices from the International Stereotactic Body Radiotherapy Consortium (Isbrtc) for Head and Neck CancersFuture Oncology, 2016
- Emergence of Stereotactic Body Radiation Therapy and Its Impact on Current and Future Clinical PracticeJournal of Clinical Oncology, 2014